PDF inhibitors (EntreMed)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePDF inhibitors (EntreMed)
Drug Alias NamePDF inhibitors (Miikana)peptide deformylase inhibitors (Miikana)peptide deformylase inhibitors (EntreMed)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptide deformylase inhibitors
TargetsPeptide deformylase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMiikana Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCasi Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A